Results 241 to 250 of about 157,119 (339)
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy [PDF]
Azab, Abdel Kareem +9 more
core +1 more source
Schematic illustrating the mechanism by which the peptide Angio‐3 attenuates pulmonary fibrosis. Following lung injury, activation of the coagulation cascade via Factor Xa (FXa) signals through protease‐activated receptor‐1 (PAR‐1) to activate fibroblasts and promote fibrosis.
Dan Wang +9 more
wiley +1 more source
Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview
ABSTRACT The practical aspects of developing curative treatments for sickle cell disease (SCD) in Africa, such as gene therapy and hematopoietic stem cell transplantation, involve strengthening healthcare infrastructure, training healthcare professionals, establishing regional treatment centers, and creating national SCD programs.
Adetola A. Kassim +2 more
wiley +1 more source
[Retracted] EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas. [PDF]
Li RH, Huang WH, Wu JD, Du CW, Zhang GJ.
europepmc +1 more source
Patients with Parkinson's disease showed poorer social cognition overall regardless of gene. There is an interplay between PD, rs2966700, and positive emotion recognition. PD patients carrying the C allele on rs2966700 performed poorer, suspected due to decreased EPHA1‐AS1 activity and increased inflammation.
Yu‐Chen Lin +3 more
wiley +1 more source
WHIM syndrome in a child without the classic tetrad: a case confirmed by de novo CXCR4 mutation. [PDF]
Al Lohaibi R +6 more
europepmc +1 more source
In our study, B cells are activated with the assistance of Breg and Tfh cells, subsequently differentiating into IgA+ plasma cells. These plasma cells produce secretory IgA (sIgA) at mucosal surfaces to combat viral and parasitic infections. Mechanistically, Fgl2 directly binds to Rack1.
Jiang Chang +10 more
wiley +1 more source
Expression of the CXCR4 S338X Variant Improves Anti-Leukemia Efficacy of Anti-CD19 CAR-T Cells. [PDF]
Mao Y +12 more
europepmc +1 more source

